SAFE-T-SYRINGE Trademark

Trademark Overview


On Tuesday, January 31, 2012, a trademark application was filed for SAFE-T-SYRINGE with the United States Patent and Trademark Office. The USPTO has given the SAFE-T-SYRINGE trademark a serial number of 85530271. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Thursday, August 29, 2019. This trademark is owned by Asepsis Pharmaceuticals Inc.. The SAFE-T-SYRINGE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of d...
safe-t-syringe

General Information


Serial Number85530271
Word MarkSAFE-T-SYRINGE
Filing DateTuesday, January 31, 2012
Status701 - SECTION 8 - ACCEPTED
Status DateThursday, August 29, 2019
Registration Number4519370
Registration DateTuesday, April 22, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-infectives; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Potassium preparations for pharmaceutical purposes
Pseudo MarkSAFETY-SYRINGE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 6, 2012
Primary Code005
First Use Anywhere DateTuesday, January 31, 2012
First Use In Commerce DateTuesday, January 31, 2012

Trademark Owner History


Party NameAsepsis Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSarasota, FL 34234

Party NameAsepsis Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Stonington, CT 06359

Trademark Events


Event DateEvent Description
Saturday, April 22, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, August 29, 2019NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Thursday, August 29, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, August 29, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 12, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 12, 2019TEAS SECTION 8 RECEIVED
Monday, April 22, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, April 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 22, 2014REGISTERED-SUPPLEMENTAL REGISTER
Saturday, March 15, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 6, 2014APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, March 6, 2014SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, September 5, 2013REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, February 26, 2013NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Sunday, February 24, 2013CORRESPONDENCE E-MAILED
Sunday, February 24, 2013SUSPENSION LETTER WRITTEN
Sunday, February 24, 2013USE AMENDMENT ACCEPTED
Sunday, February 24, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 22, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, February 24, 2013AMENDMENT TO USE PROCESSING COMPLETE
Sunday, February 24, 2013USE AMENDMENT FILED
Sunday, February 24, 2013ASSIGNED TO LIE
Friday, February 22, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 22, 2013TEAS AMENDMENT OF USE RECEIVED
Friday, January 4, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 4, 2013NON-FINAL ACTION E-MAILED
Friday, January 4, 2013NON-FINAL ACTION WRITTEN
Wednesday, November 21, 2012NOTICE OF REVIVAL - E-MAILED
Wednesday, November 21, 2012PETITION TO REVIVE-GRANTED
Wednesday, November 21, 2012TEAS PETITION TO REVIVE RECEIVED
Monday, October 22, 2012ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, October 22, 2012ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 26, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 26, 2012NON-FINAL ACTION E-MAILED
Monday, March 26, 2012NON-FINAL ACTION WRITTEN
Saturday, March 17, 2012ASSIGNED TO EXAMINER
Tuesday, February 7, 2012NOTICE OF PSEUDO MARK MAILED
Monday, February 6, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 3, 2012NEW APPLICATION ENTERED